[
  {
    "ts": null,
    "headline": "Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices",
    "summary": "The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump administration calls for the industry to cut prices.",
    "url": "https://finnhub.io/api/news?id=85d22235e76bdfb48f00a2dbf07f7e4edf9f9c127f7c5267e3dbc612394fe3b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753370160,
      "headline": "Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices",
      "id": 136068056,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump administration calls for the industry to cut prices.",
      "url": "https://finnhub.io/api/news?id=85d22235e76bdfb48f00a2dbf07f7e4edf9f9c127f7c5267e3dbc612394fe3b6"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?",
    "summary": "BMY rises 6.3% in a month as investors pin hopes on new drugs to offset pressure from pipeline and patent losses.",
    "url": "https://finnhub.io/api/news?id=501be251bd192d0235da68db1b3fa692c3a327e253e929f781afa5355f5a74f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753368540,
      "headline": "Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?",
      "id": 136084964,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY rises 6.3% in a month as investors pin hopes on new drugs to offset pressure from pipeline and patent losses.",
      "url": "https://finnhub.io/api/news?id=501be251bd192d0235da68db1b3fa692c3a327e253e929f781afa5355f5a74f0"
    }
  },
  {
    "ts": null,
    "headline": "Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for",
    "summary": "Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=8ae0bd98ec950020a2f5063cdec4d1c5e342bd535e181a650da1f3ef3c28e7a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753365608,
      "headline": "Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for",
      "id": 136068153,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=8ae0bd98ec950020a2f5063cdec4d1c5e342bd535e181a650da1f3ef3c28e7a9"
    }
  },
  {
    "ts": null,
    "headline": "Bausch Health Announces the Appointment of Two New Members to Its Board of Directors",
    "summary": "LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Michael Goettler and Sandra Leung to its Board of Directors, effective ...",
    "url": "https://finnhub.io/api/news?id=fac73ea61fd5bdda50874da0c5a8f33aef6984dda95cc5803dce528fdfaea028",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753358520,
      "headline": "Bausch Health Announces the Appointment of Two New Members to Its Board of Directors",
      "id": 136066534,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Michael Goettler and Sandra Leung to its Board of Directors, effective ...",
      "url": "https://finnhub.io/api/news?id=fac73ea61fd5bdda50874da0c5a8f33aef6984dda95cc5803dce528fdfaea028"
    }
  },
  {
    "ts": null,
    "headline": "ModelOp Transforms Enterprise AI Governance with Launch of the First Agentic AI Chat Interface and Controls for Agentic AI",
    "summary": "ModelOp’s new Agentic AI Chat Interface and end-to-end lifecycle automation tools for Agentic AI mark a leapfrog in technology providing enterprises with better control for autonomous innovationCHICAGO, July 24, 2025 (GLOBE NEWSWIRE) -- ModelOp, the leading AI lifecycle automation and governance software for enterprises, announced today the launch of the world’s first comprehensive toolset for governing Agentic AI. The roll out marks a transformative leap in both usability and control for large",
    "url": "https://finnhub.io/api/news?id=34d8cc8b17624e7f3fc1ab9bb3b45676fb88e3a9450c9e3f7689f0a03a3f70dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753358100,
      "headline": "ModelOp Transforms Enterprise AI Governance with Launch of the First Agentic AI Chat Interface and Controls for Agentic AI",
      "id": 136066535,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "ModelOp’s new Agentic AI Chat Interface and end-to-end lifecycle automation tools for Agentic AI mark a leapfrog in technology providing enterprises with better control for autonomous innovationCHICAGO, July 24, 2025 (GLOBE NEWSWIRE) -- ModelOp, the leading AI lifecycle automation and governance software for enterprises, announced today the launch of the world’s first comprehensive toolset for governing Agentic AI. The roll out marks a transformative leap in both usability and control for large",
      "url": "https://finnhub.io/api/news?id=34d8cc8b17624e7f3fc1ab9bb3b45676fb88e3a9450c9e3f7689f0a03a3f70dd"
    }
  },
  {
    "ts": null,
    "headline": "How Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab",
    "summary": "The company’s AI approach allows molecule candidates to be vetted for efficacy and other properties early in development.",
    "url": "https://finnhub.io/api/news?id=51b67fce725b52d3d4ad3ae620e0afdc5627070dbb4e68102752c7a31cbd7fce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753344000,
      "headline": "How Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab",
      "id": 136066536,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The company’s AI approach allows molecule candidates to be vetted for efficacy and other properties early in development.",
      "url": "https://finnhub.io/api/news?id=51b67fce725b52d3d4ad3ae620e0afdc5627070dbb4e68102752c7a31cbd7fce"
    }
  },
  {
    "ts": null,
    "headline": "Q1 Earnings Recap: Bristol-Myers Squibb (NYSE:BMY) Tops Branded Pharmaceuticals Stocks",
    "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best and worst performers in the branded pharmaceuticals industry.",
    "url": "https://finnhub.io/api/news?id=a14d5ea5248a8b07371a3e56c625550ad08be9c567cf2229603d763d1339bf1e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753327911,
      "headline": "Q1 Earnings Recap: Bristol-Myers Squibb (NYSE:BMY) Tops Branded Pharmaceuticals Stocks",
      "id": 136066537,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best and worst performers in the branded pharmaceuticals industry.",
      "url": "https://finnhub.io/api/news?id=a14d5ea5248a8b07371a3e56c625550ad08be9c567cf2229603d763d1339bf1e"
    }
  }
]